Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 7, Pages 1448
Publisher
MDPI AG
Online
2022-07-12
DOI
10.3390/pharmaceutics14071448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomaterials as Antigen Delivery Carrier for Cancer Immunotherapy
- (2022) Wooram Um et al. MACROMOLECULAR RESEARCH
- PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
- (2021) Julia Koerner et al. Nature Communications
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
- (2020) Bo Sun et al. ACTA PHARMACOLOGICA SINICA
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- D‐Peptide Builder: A Web Service to Enumerate, Analyze, and Visualize the Chemical Space of Combinatorial Peptide Libraries
- (2020) Bárbara I. Díaz‐Eufracio et al. Molecular Informatics
- Best practices for variant calling in clinical sequencing
- (2020) Daniel C. Koboldt Genome Medicine
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
- (2019) Karim Vermaelen Frontiers in Immunology
- A 3D Macroporous Alginate Graphene Scaffold with an Extremely Slow Release of a Loaded Cargo for In Situ Long-Term Activation of Dendritic Cells
- (2019) Arjyabaran Sinha et al. Advanced Healthcare Materials
- Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy
- (2019) Linhua Zhang et al. NANO LETTERS
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer
- (2019) Ping Zhou et al. BIOMATERIALS
- Advances in immunotherapy delivery from implantable and injectable biomaterials
- (2019) David G. Leach et al. Acta Biomaterialia
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- NOD-like receptor signaling in inflammation-associated cancers: from functions to targeted therapies
- (2019) Peng LIU et al. PHYTOMEDICINE
- In Situ Nanoadjuvant-Assembled Tumor Vaccine for Preventing Long-Term Recurrence
- (2019) Quoc-Viet Le et al. ACS Nano
- Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination
- (2019) Dunwan Zhu et al. BIOMATERIALS
- Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod
- (2019) Mariya Rozenblit et al. Scientific Reports
- Advances in alkaline water electrolyzers: A review
- (2019) Martín David et al. Journal of Energy Storage
- Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
- (2019) Yasuhiro Shimizu et al. CANCER SCIENCE
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- Delivery strategies of cancer immunotherapy: recent advances and future perspectives
- (2019) Zhongwei Zhao et al. Journal of Hematology & Oncology
- The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
- (2018) Marian Christoph Neidert et al. ACTA NEUROPATHOLOGICA
- Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
- (2018) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information
- (2018) S Kim et al. ANNALS OF ONCOLOGY
- Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase
- (2018) Xiuwen Guan et al. BIOMATERIALS
- Dynamic Structural Differences between Human and Mouse STING Lead to Differing Sensitivity to DMXAA
- (2018) Amy Y. Shih et al. BIOPHYSICAL JOURNAL
- Current challenges for cancer vaccine adjuvant development
- (2018) William S. Bowen et al. Expert Review of Vaccines
- Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation
- (2018) Jérôme Widmer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Extending antigen release from particulate vaccines results in enhanced antitumor immune response
- (2018) Chintan H. Kapadia et al. JOURNAL OF CONTROLLED RELEASE
- An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines
- (2018) Pedro O. Flores-Villanueva et al. JOURNAL OF IMMUNOLOGY
- Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination
- (2018) Yufei Xia et al. NATURE MATERIALS
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer
- (2018) Qiongshu Li et al. Oncology Letters
- Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy
- (2018) Naoto Nishii et al. Oncotarget
- The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
- (2018) Chunhui Lai et al. Theranostics
- Injectable, Tough Alginate Cryogels as Cancer Vaccines
- (2018) Ting-Yu Shih et al. Advanced Healthcare Materials
- Systematic Analysis of Splice-Site-Creating Mutations in Cancer
- (2018) Reyka G. Jayasinghe et al. Cell Reports
- Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
- (2018) Andrew J. Rech et al. Cancer Immunology Research
- Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
- (2018) Alex Rubinsteyn et al. Frontiers in Immunology
- Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
- (2018) Yugang Guo et al. Frontiers in Immunology
- Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses
- (2018) Jing Wei Jin et al. Acta Biomaterialia
- Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
- (2018) Robert A. Jabulowsky et al. CANCER RESEARCH
- Identification of non-mutated neoantigens presented by TAP-deficient tumors
- (2018) Koen A. Marijt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Design, synthesis, and biological evaluation of C7-functionalized DMXAA derivatives as potential human-STING agonists
- (2018) Jihyun Hwang et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Polysaccharides as vaccine adjuvants
- (2018) Beini Sun et al. VACCINE
- Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
- (2018) Christof C. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
- (2018) Michael A. Collier et al. MOLECULAR PHARMACEUTICS
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
- (2018) Aurélie Durgeau et al. Nature Communications
- Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer
- (2017) Mariela A. Moreno Ayala et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development
- (2017) Banu Bayyurt et al. JOURNAL OF CONTROLLED RELEASE
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides
- (2017) Chunsong Yu et al. MOLECULAR PHARMACEUTICS
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
- (2017) Tyler J. Goodwin et al. VACCINE
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- The neoepitope landscape in pediatric cancers
- (2017) Ti-Cheng Chang et al. Genome Medicine
- Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses
- (2017) Mahboubeh Ebrahimian et al. Frontiers in Immunology
- Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
- (2017) Marek Wieczorek et al. Frontiers in Immunology
- TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
- (2017) Zhan Zhou et al. Royal Society Open Science
- INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery
- (2016) Jin Zhang et al. BIOINFORMATICS
- Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands
- (2016) Vincent Pavot et al. BIOMATERIALS
- Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses
- (2016) Andrew J. Highton et al. BMC IMMUNOLOGY
- Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4
- (2016) Marc Lopez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer
- (2016) Elena Cherkasova et al. CANCER RESEARCH
- Expression of surface and intracellular Toll-like receptors by mature mast cells
- (2016) Justyna Agier et al. Central European Journal of Immunology
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling
- (2016) Song Jiang et al. JOURNAL OF IMMUNOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine
- (2016) Hye-Mi Park et al. VACCINE
- NOD-Like Receptors in Infection, Immunity, and Diseases
- (2016) Young Keun Kim et al. YONSEI MEDICAL JOURNAL
- pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
- (2016) Jasreet Hundal et al. Genome Medicine
- From discovery to licensure, the Adjuvant System story
- (2016) Nathalie Garçon et al. Human Vaccines & Immunotherapeutics
- Adjuvants: Classification,Modus Operandi, and Licensing
- (2016) Juliana de Souza Apostólico et al. Journal of Immunology Research
- An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs
- (2016) Masatoshi Hirayama et al. OncoImmunology
- Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy
- (2016) Kei Ishibashi et al. OncoImmunology
- TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
- (2016) Thibaud Spinetti et al. OncoImmunology
- In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
- (2016) Hee Dong Han et al. Scientific Reports
- InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity
- (2015) Feifan Zhou et al. CANCER LETTERS
- Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma
- (2015) Andrew J Highton et al. IMMUNOLOGY AND CELL BIOLOGY
- Vascular endothelial cell Toll-like receptor pathways in sepsis
- (2015) Samira Khakpour et al. Innate Immunity
- Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes
- (2015) CHENG YAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
- (2015) Rachid Ammi et al. PHARMACOLOGY & THERAPEUTICS
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
- (2015) Olivier Demaria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Injectable cryogel-based whole-cell cancer vaccines
- (2015) Sidi A. Bencherif et al. Nature Communications
- Oncogenic cancer/testis antigens: prime candidates for immunotherapy
- (2015) Morten F. Gjerstorff et al. Oncotarget
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- DNA vaccines, electroporation and their applications in cancer treatment
- (2015) Si-Hyeong Lee et al. Human Vaccines & Immunotherapeutics
- An optimized peptide vaccine strategy capable of inducing multivalent CD8+T cell responses with potent antitumor effects
- (2015) Hyun-Il Cho et al. OncoImmunology
- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
- (2014) M. Rajasagi et al. BLOOD
- Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors
- (2014) Toshihiro Nagato et al. CLINICAL CANCER RESEARCH
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- Toll-like receptors and B cells: functions and mechanisms
- (2014) Claire M. Buchta et al. IMMUNOLOGIC RESEARCH
- CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
- (2014) Charline Vauchy et al. INTERNATIONAL JOURNAL OF CANCER
- TLR Cross-talk Confers Specificity to Innate Immunity
- (2014) Rebecca S. T. Tan et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Correction: MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2014) Angelika Banzhoff et al. PLoS One
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens
- (2014) Ryan McClure et al. Frontiers in Immunology
- Identification of immunogenic LY6K long peptide encompassing both CD4+and CD8+T-cell epitopes and eliciting CD4+T-cell immunity in patients with malignant disease
- (2014) Yusuke Tomita et al. OncoImmunology
- Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma
- (2013) Yoon Joong Kang et al. BRITISH JOURNAL OF HAEMATOLOGY
- New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?
- (2013) V Boncheva et al. CANCER GENE THERAPY
- HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
- (2013) S. Munir et al. CANCER RESEARCH
- Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
- (2013) Pu Gao et al. CELL
- Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
- (2013) Kai Naumann et al. Clinical & Developmental Immunology
- Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
- (2013) Darin A. Wick et al. CLINICAL CANCER RESEARCH
- TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals
- (2013) Minou Adib-Conquy et al. IMMUNOLOGY AND CELL BIOLOGY
- The Signal Peptide of the Tumor-shared Antigen Midkine Hosts CD4+T Cell Epitopes
- (2013) Jerome Kerzerho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties
- (2013) Vincent Pavot et al. JOURNAL OF CONTROLLED RELEASE
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes from Human Hepsin as Novel Targets for Prostate Cancer Immunotherapy
- (2013) J. Guo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A microarray method for identifying tumor antigens by screening a tumor cDNA expression library against cancer sera
- (2013) Kurt Whittemore et al. Human Vaccines & Immunotherapeutics
- Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
- (2012) S. Ochsenreither et al. BLOOD
- BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
- (2012) Hyun-Il Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells
- (2012) Vincent Stroobant et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
- (2012) Colleen Olive Expert Review of Vaccines
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- CD8+ T-cell Clones Specific for the 5T4 Antigen Target Renal Cell Carcinoma Tumor-initiating Cells in a Murine Xenograft Model
- (2012) Scott S. Tykodi et al. JOURNAL OF IMMUNOTHERAPY
- Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses
- (2012) Hideo Negishi et al. NATURE IMMUNOLOGY
- MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
- (2012) Mathilde Bobinet et al. PLoS One
- Type I interferon response and innate immune sensing of cancer
- (2012) Mercedes B. Fuertes et al. TRENDS IN IMMUNOLOGY
- Virosome: A novel vector to enable multi-modal strategies for cancer therapy
- (2011) Yasufumi Kaneda ADVANCED DRUG DELIVERY REVIEWS
- Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma
- (2011) Larry D. Anderson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma
- (2011) Oliver C. Goodyear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients
- (2011) Ray Wilkinson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses
- (2011) Frank Neumann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
- (2011) Véronique Corbière et al. CANCER RESEARCH
- A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells
- (2011) Yusuke Tomita et al. CANCER SCIENCE
- Identification of promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the cancer-testis antigen HCA587
- (2011) Weigang Wen et al. CANCER SCIENCE
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Current adjuvants and new perspectives in vaccine formulation
- (2011) Emanuele Montomoli et al. Expert Review of Vaccines
- Immune Signaling by RIG-I-like Receptors
- (2011) Yueh-Ming Loo et al. IMMUNITY
- A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy
- (2011) Wenbin Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients
- (2011) Yoshihiro Ohue et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin
- (2011) Tetsuya Nakatsura INTERNATIONAL JOURNAL OF ONCOLOGY
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of HLA-A*0201- and A*2402-Restricted Epitopes of Mucin 5AC Expressed in Advanced Pancreatic Cancer
- (2011) Sadaaki Yamazoe et al. PANCREAS
- Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients
- (2011) Xiaosong Li et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
- (2011) Dmitri Smirnov et al. VACCINE
- Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer
- (2010) K Imai et al. BRITISH JOURNAL OF CANCER
- A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination
- (2010) Anne Rogel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
- (2010) Brian M. Olson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells
- (2010) Yusuke Tomita et al. CANCER SCIENCE
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- The Angiogenic Growth Factor and Biomarker Midkine Is a Tumor-Shared Antigen
- (2010) J. Kerzerho et al. JOURNAL OF IMMUNOLOGY
- Retinoic Acid-Inducible Gene-I-Like Receptors
- (2010) Kazuhide Onoguchi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries
- (2010) Wolfram Osen et al. PLoS One
- Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients
- (2010) N. Nuber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients
- (2010) Yu Mizote et al. VACCINE
- A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design
- (2009) L. M. Ebert et al. CANCER RESEARCH
- Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire
- (2009) G. Bioley et al. CLINICAL CANCER RESEARCH
- Mechanism of action of clinically approved adjuvants
- (2009) Bart N Lambrecht et al. CURRENT OPINION IN IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- The TAG Family of Cancer/Testis Antigens is Widely Expressed in a Variety of Malignancies and Gives Rise to HLA-A2–Restricted Epitopes
- (2009) Sara J. Adair et al. JOURNAL OF IMMUNOTHERAPY
- Activation of innate immune antiviral responses by Nod2
- (2009) Ahmed Sabbah et al. NATURE IMMUNOLOGY
- Unleashing the therapeutic potential of NOD-like receptors
- (2009) Kaoru Geddes et al. NATURE REVIEWS DRUG DISCOVERY
- The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
- (2009) Rikke Bæk Sørensen et al. PLoS One
- Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma
- (2008) O. C. Goodyear et al. BLOOD
- RhoC a new target for therapeutic vaccination against metastatic cancer
- (2008) Lynn Wenandy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients
- (2008) Ashley J. Knights et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
- (2008) Junko Matsuzaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays
- (2008) A. O. Weinzierl et al. CANCER RESEARCH
- Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy
- (2008) M. Yan et al. CANCER RESEARCH
- Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites
- (2008) John L. Goodier et al. CELL
- Cyclin D1-Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy
- (2008) E. Kondo et al. CLINICAL CANCER RESEARCH
- Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells
- (2008) Y. Yokoyama et al. CLINICAL CANCER RESEARCH
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells
- (2008) Yoshiyuki Takahashi et al. JOURNAL OF CLINICAL INVESTIGATION
- MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
- (2008) Yann Godet et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification
- (2008) Jens Rauch et al. Proteomics Clinical Applications
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now